Scarica l'app Stockscreener
1.01
2.42%
-0.025
Dopo l'orario di chiusura:
.99
-0.02
-1.98%
Precedente Chiudi:
$1.035
Aprire:
$1.04
Volume 24 ore:
144.35K
Relative Volume:
0.50
Capitalizzazione di mercato:
$60.94M
Reddito:
-
Utile/perdita netta:
$-112.67M
Rapporto P/E:
-0.5179
EPS:
-1.95
Flusso di cassa netto:
$-79.26M
1 W Prestazione:
-2.88%
1M Prestazione:
+6.32%
6M Prestazione:
-22.31%
1 anno Prestazione:
-10.62%
Intervallo 1D:
$0.995
$1.04
Intervallo di 1 settimana:
$0.9885
$1.05
Portata 52W:
$0.69
$1.60
Kronos Bio Inc Stock (KRON) Company Profile
Nome
Kronos Bio Inc
Settore
Industria
Telefono
(650) 781-5200
Indirizzo
1300 S. EL CAMINO REAL, SAN MATEO
Confronta KRON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRON
Kronos Bio Inc
|
1.01 | 60.94M | 0 | -112.67M | -79.26M | -1.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Kronos Bio Inc Stock (KRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-14 | Downgrade | TD Cowen | Buy → Hold |
| 2022-09-14 | Iniziato | Berenberg | Buy |
| 2021-10-20 | Ripresa | Cowen | Outperform |
| 2021-06-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-03 | Iniziato | Cowen | Outperform |
| 2020-11-03 | Iniziato | Goldman | Buy |
| 2020-11-03 | Iniziato | Jefferies | Buy |
| 2020-11-03 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Kronos Bio Inc Borsa (KRON) Ultime notizie
Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN
Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance
Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat
Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia
Kronos Bio ends partnership with Genentech - Investing.com India
Kronos Bio Ends Collaboration with Genentech and Roche - TipRanks
Kronos Bio (NASDAQ:KRON) Trading 8.5% HigherHere's Why - MarketBeat
Struggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staff - SFGATE
Biotech with Cambridge lab slashes 83% of staff, CEO departs - NBC Boston
Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates - MSN
KRON (Kronos Bio) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com
A Look At The Behavior Of Kronos Bio Inc (KRON) Stock - Stocks Register
Kronos Bio announces interim CEO; over 80% of staff reduction - MSN
Kronos Bio announces interim CEO and workforce cuts of 83% - Yahoo Finance
Strategic shift at Kronos creates CEO vacancy - The Pharma Letter
Kronos Bio to lay off 83% of staff as CEO steps down - The Business Journals
Kronos Bio announces layoffs and executive changes By Investing.com - Investing.com Nigeria
Kronos Bio, Inc. Announces Management Changes, Effective December 3, 2024 - Marketscreener.com
Kronos Bio, Inc. Announces CEO Changes, Effective December 3, 2024 - Marketscreener.com
Kronos Bio Shakes Up LeadershipCuts 83% Of Workforce Amid Strategic Overhaul - AOL
Kronos Bio announces layoffs and executive changes - Investing.com India
Kronos Bio Announces CEO Transition and Reduction in Force - The Manila Times
Kronos Bio stock in focus on CEO change, layoffs (KRON:NASDAQ) - Seeking Alpha
Kronos Bio to Cut 83% Of Workforce, Names Interim CEO - MarketWatch
Kronos Bio Cuts 83% of Workforce, Names New CEO Amid Strategic Review | KRON Stock News - StockTitan
Kronos Bio Restructures Workforce and Leadership - TipRanks
Kronos Bio : Management Change/Compensation Form 8 K - Marketscreener.com
Kronos, Idorsia plan layoffs; PTC shelves ALS drug - Yahoo Finance
Kronos Bio Inc Azioni (KRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.95%
2.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):